Heartflow Inc. reported total revenue of $46.3 million for the third quarter of 2025, a 41% increase year-over-year. The company posted a gross margin of 76.5% and a net operating loss of $15.1 million, with a non-GAAP net operating loss of $11.1 million. Heartflow completed its initial public offering, raising approximately $364.2 million in gross proceeds. The company launched its next-generation Heartflow Plaque Analysis and noted that UnitedHealthcare and Cigna began coverage of this service on October 1, 2025. Heartflow expects full year 2025 revenue to range from $173.0 million to $173.5 million, representing an anticipated year-over-year growth of approximately 37.5% to 38%.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001464521-25-000018), on November 12, 2025, and is solely responsible for the information contained therein.